Publicly Traded Diabetes Companies
List of Publicly Traded Diabetes Companies Listed on U.S. Exchanges
The publicly traded companies on this list are biotech, medical device, pharmaceutical companies or other healthcare companies that design, develop, manufacture and/or distribute drugs, equipment, products, systems and/or services relating to diabetes. Examples of the products and services provided by these companies include:
- Distribution of diabetes products and supplies
- Glucose monitoring systems
- Insulin delivery systems
- Insulin pumps
- Therapeutic products
Most of the large-cap stocks in this category have diabetes products (drugs, therapeutics, devices, etc.) in addition to products in numerous other areas.
Resources:
Additional publicly traded healthcare companies and healthcare categories can be accessed through the link below:
List of Publicly Traded Healthcare Companies
A comparison widget that shows trend, earnings per share (EPS), P/E ratio and beta for each of the companies on this list can be accessed through the link below.
Diabetes Industry Comparison Widget
Select the company’s link to access charts, news links and company website and social media information.
Diabetes Treatment: Large-Cap Stocks
Becton, Dickinson and Company (BDX) (Management of diabetes among many devices and diagnostic products)
Eli Lilly and Company (LLY) (Animal health, cardiovascular, critical care, diabetes, men’s health, musculoskeletal, neuroscience, oncology)
Johnson & Johnson (JNJ) (Pharmaceutical company: diabetes products among many offerings)
Medtronic, Inc. (MDT) (Medical device company: diabetes products among many offerings)
Novo Nordisk (NVO) (Denmark: diabetes and other serious chronic conditions)
Regeneron Pharmaceuticals, Inc. (REGN) (Biopharmaceutical company: antibody technologies; cardiovascular, diabetes, eye diseases, infectious diseases, inflammation, oncology, pain)
Sanofi (SNY) (France: animal health products, consumer healthcare products, generic drugs, vaccines; drugs for diabetes, rare diseases, multiple sclerosis and oncology)
Diabetes: Mid-Cap Stocks
DexCom, Inc. (DXCM) (Glucose monitoring systems)
Insulet Corporation (PODD) (Tubeless insulin pump; distributor of diabetes products and supplies)
Myriad Genetics, Inc. (MYGN) (Diagnostics: hereditary cancer, nephrology, autoimmune diseases, diabetes, neuropsychiatry)
Diabetes: Small-Cap Stocks
Lexicon Pharmaceuticals, Inc. (LXRX) (Biopharmaceutical company: treatment of type 1 and type 2 diabetes, treatment of carcinoid syndrome)
Diabetes: Micro-Cap Stocks
MannKind Corporation (MNKD) (Biopharmaceutical company: therapeutic products for diseases which include diabetes)
Senseonics Holdings, Inc. (SENS) (IPO March 18, 2016: Develops glucose monitoring systems)
Tandem Diabetes Care, Inc. (TNDM) (Insulin delivery system)
Trinity Biotech Plc. (TRIB) (Ireland: tests for autoimmune disorders, cardiac arrest, diabetes, infectious diseases and sexually transmitted diseases)
VTV Therapeutics Inc. (VTVT) (IPO in July 2015: Clinical stage pharmaceutical company: cancer, central nervous system disorders, diabetes and metabolic disorders, inflammation)
Diabetes: Nano-Cap Stocks
DarioHealth Corp. (DRIO) (Israel: cloud-based, diabetes management solution)
Valeritas Holdings, Inc. (VLRX) (IPO March 23, 2017; V-Go Wearable Insulin Delivery Device)
Related Links:
List of Pharmaceutical Companies
Publicly Traded Companies by Sector and Industry